These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12724757)

  • 21. Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation.
    El-Armouche A; Boknik P; Eschenhagen T; Carrier L; Knaut M; Ravens U; Dobrev D
    Circulation; 2006 Aug; 114(7):670-80. PubMed ID: 16894034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diastolic dysfunction and the aging heart.
    Chiamvimonvat N
    J Mol Cell Cardiol; 2002 Jun; 34(6):607-10. PubMed ID: 12054847
    [No Abstract]   [Full Text] [Related]  

  • 23. Gene therapy for heart failure.
    Nayak L; Rosengart TK
    Semin Thorac Cardiovasc Surg; 2005; 17(4):343-7. PubMed ID: 16428042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy targeted at calcium handling as an approach to the treatment of heart failure.
    Hoshijima M
    Pharmacol Ther; 2005 Mar; 105(3):211-28. PubMed ID: 15737405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased cardiomyocyte function and Ca2+ transients in mice during early congestive heart failure.
    Mørk HK; Sjaastad I; Sande JB; Periasamy M; Sejersted OM; Louch WE
    J Mol Cell Cardiol; 2007 Aug; 43(2):177-86. PubMed ID: 17574269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of long-term treatment of imidapril on mortality, cardiac function, and gene expression in congestive heart failure due to myocardial infarction.
    Ren B; Shao Q; Ganguly PK; Tappia PS; Takeda N; Dhalla NS
    Can J Physiol Pharmacol; 2004 Dec; 82(12):1118-27. PubMed ID: 15644955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of phospholamban in the pathogenesis of heart failure.
    Waggoner JR; Kranias EG
    Heart Fail Clin; 2005 Jul; 1(2):207-18. PubMed ID: 17386847
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug development based on functional genomics of overloaded cardiomyocytes: a novel approach for preventing progression of heart failure.
    Rupp H
    J Muscle Res Cell Motil; 2004; 25(8):608-9. PubMed ID: 16118846
    [No Abstract]   [Full Text] [Related]  

  • 29. The sarcoplasmic reticulum proteins are targets for calpain action in the ischemic-reperfused heart.
    Singh RB; Chohan PK; Dhalla NS; Netticadan T
    J Mol Cell Cardiol; 2004 Jul; 37(1):101-10. PubMed ID: 15242740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphic SERCA2a variants do not account for inter-individual differences in phospholamban-SERCA2a interactions in human heart failure.
    Schmidt AG; Haghighi K; Frank B; Pater L; Dorn GW; Walsh RA; Kranias EG
    J Mol Cell Cardiol; 2003 Jul; 35(7):867-70. PubMed ID: 12818578
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of impaired calcium homeostasis in the development of cardiac hypertrophy].
    Kieć-Wilk B; Petkow-Dimitrow P; Kwaśniak M; Dembińska-Kieć A
    Kardiol Pol; 2009 Dec; 67(12):1396-402. PubMed ID: 20054774
    [No Abstract]   [Full Text] [Related]  

  • 32. Increased nitration of sarcoplasmic reticulum Ca2+-ATPase in human heart failure.
    Lokuta AJ; Maertz NA; Meethal SV; Potter KT; Kamp TJ; Valdivia HH; Haworth RA
    Circulation; 2005 Mar; 111(8):988-95. PubMed ID: 15710754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exercise training improves the net balance of cardiac Ca2+ handling protein expression in heart failure.
    Rolim NP; Medeiros A; Rosa KT; Mattos KC; Irigoyen MC; Krieger EM; Krieger JE; Negrão CE; Brum PC
    Physiol Genomics; 2007 May; 29(3):246-52. PubMed ID: 17244791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of junctin causes adaptive changes in cardiac myocyte Ca(2+) signaling.
    Kirchhefer U; Hanske G; Jones LR; Justus I; Kaestner L; Lipp P; Schmitz W; Neumann J
    Cell Calcium; 2006 Feb; 39(2):131-42. PubMed ID: 16289269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermolecular conformational coupling and free energy exchange enhance the catalytic efficiency of cardiac muscle SERCA2a following the relief of phospholamban inhibition.
    Mahaney JE; Albers RW; Waggoner JR; Kutchai HC; Froehlich JP
    Biochemistry; 2005 May; 44(21):7713-24. PubMed ID: 15909986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear targeting of Akt enhances ventricular function and myocyte contractility.
    Rota M; Boni A; Urbanek K; Padin-Iruegas ME; Kajstura TJ; Fiore G; Kubo H; Sonnenblick EH; Musso E; Houser SR; Leri A; Sussman MA; Anversa P
    Circ Res; 2005 Dec; 97(12):1332-41. PubMed ID: 16293788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Manipulating cardiac contractility in heart failure: data from mice and men.
    Dorn GW; Molkentin JD
    Circulation; 2004 Jan; 109(2):150-8. PubMed ID: 14734503
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation.
    Gramolini AO; Trivieri MG; Oudit GY; Kislinger T; Li W; Patel MM; Emili A; Kranias EG; Backx PH; Maclennan DH
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2446-51. PubMed ID: 16461894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transport mechanism of the sarcoplasmic reticulum Ca2+ -ATPase pump.
    Møller JV; Nissen P; Sørensen TL; le Maire M
    Curr Opin Struct Biol; 2005 Aug; 15(4):387-93. PubMed ID: 16009548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression.
    Kögler H; Schott P; Toischer K; Milting H; Van PN; Kohlhaas M; Grebe C; Kassner A; Domeier E; Teucher N; Seidler T; Knöll R; Maier LS; El-Banayosy A; Körfer R; Hasenfuss G
    Circulation; 2006 Jun; 113(23):2724-32. PubMed ID: 16754798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.